過去40年間にわたり, сепティックショックに対する新しい治療法が開発されました
Anthony F Suffredini1, Robert S Munford
1Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bldg 10, Rm 2C145, Bethesda, MD 20892, USA. asuffredini@cc.nih.gov
JAMA
|July 14, 2011
まとめ
重度のセプシスとセプシスショックは,生命を脅かす感染症であり,臓器不全を引き起こし,世界的な医療費を大幅に負担します. 何十年もの研究にもかかわらず,効果的な新しい治療法は未だに捉え難いままであり,集中治療医療におけるイノベーションの必要性を強調しています.
科学分野:
- クリティカルケア医療は,重症治療薬です.
- 感染症 感染症は感染症です.
- 公衆衛生は公衆衛生である.
背景:
- 重度のセプシスとセプティックショックは,すべての年齢層に影響を及ぼし,慢性疾患を悪化させ,世界的な健康負担を大きくしています.
- これらの状態は,集中治療室での死亡の主な原因であり,医療費に大きく貢献しています.
- これらの感染症の効果的な臨床実践に科学的進歩を翻訳することは,過去40年間にわたって挑戦的であることが証明されています.
関連する概念動画
Microorganisms in Medicine and Therapeutics
845
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
845
Acute Pyelonephritis II: Diagnostic Studies and Management
215
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
215
Cardiopulmonary Resuscitation IV: Pharmacological Management
442
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
442
Heart Failure VI: Adjunct Therapies
186
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
186
Acute Coronary Syndrome IV: Interprofessional Care
170
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
170
Pneumonia IV: Management
669
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
669


